UBS Group’s Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares CLVT.PRA Stock Holding History

UBS Group’s Portfolio CLVT.PRA Stock Details CLVT.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4	Closed	-$119	–	10364
2024 Q1	$119	Buy	+4	New	+$136	﹤0.01%	8813
2023 Q4	–	Sell	-100	Closed	-$2.92K	–	10216
2023 Q3	$2.92K	Buy	+100	New	+$3.47K	﹤0.01%	7627
2023 Q1	–	Sell	-310	Closed	-$11.7K	–	10789
2022 Q4	$11.7K	Sell	310 -424	-58%	-$17.8K	﹤0.01%	8361
2022 Q3	$31K	Buy	+734	New	+$39K	﹤0.01%	6850

UBS Group's CLVT.PRA Position: Q2 2024 in Review

UBS Group sold out of Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares (CLVT.PRA) in Q2 2024, closing a stake of 4 shares — an estimated $119 sold.

UBS Group first reported a position in CLVT.PRA in Q3 2022 and held it in 4 quarters. The position peaked at $31K in Q3 2022. 0 funds tracked by Wall St. Rank hold CLVT.PRA as of Q2 2024.

UBS Group reported no remaining Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position as of Q2 2024 after selling out during the quarter.
UBS Group sold 4 Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares shares in Q2 2024, an estimated $119.
UBS Group first reported a position in Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares in Q3 2022 and held it in 4 quarters.
UBS Group's Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position peaked at $31K in Q3 2022.
0 funds tracked by Wall St. Rank held Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.